Imatinib Base 152459-95-5
Imatinib is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It was originally coded during development as CGP57148B or STI-571 (these terms are used in early preclinical publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies.
read more [+]| Systematic (IUPAC) name: | |
|---|---|
| Imatinib Base CAS number: | 152459-95-5 |
| ATC code: | |
| PubChem: | |
| DrugBank: | |
| Formula: | |
| Molecular mass: | g/mol |
| Imatinib Base Assay/Purity: | Typically NLT 98% |
